𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of meta-analysis of clinical trials for Alzheimer's disease

✍ Scribed by Jesús M. López Arrieta

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
108 KB
Volume
56
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of longitudinal data in an Alzh
Analysis of longitudinal data in an Alzheimer's disease clinical trial
✍ Ronald G. Thomas; Julie D. Berg; Mary Sano; Leon Thal 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Evidence of delayed progression is the primary mechanism for demonstrating therapeutic e cacy in clinical trials in Alzheimer's disease. In the major trials of therapeutic treatment of AD, to date, measures based on clinical judgement and cognitive performance, instead of mortality, have been used a

The effect of selegiline in the treatmen
The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials
✍ G. K. Wilcock; J. Birks; A. Whitehead; Sir John Grimley Evans 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## Objective To evaluate the effect of selegiline in the treatment of patients with Alzheimer's disease, in terms of cognitive performance, functional ability, emotional state (including behaviour and mood) and global response. ## Data Sources The Cochrane database of trials, Embase,

The significance of clinical trials and
The significance of clinical trials and the role of meta-analyses
✍ Bartolucci, Al 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Much of the literature is turning attention to metaanalyses. This may be positive in light of the many underpowered studies that have been reported. However, one must step back and put this activity in perspective and not lose sight of the important role of the clinical trial in research. Further e